Metformin promotes apoptosis in hepatocellular carcinoma through the CEBPD-induced autophagy pathway. 2017

Hsin-Hwa Tsai, and Hong-Yue Lai, and Yueh-Chiu Chen, and Chien-Feng Li, and Huei-Sheng Huang, and Hsiao-Sheng Liu, and Yau-Sheng Tsai, and Ju-Ming Wang
Institute of Bioinformatics and Biosignal Transduction, National Cheng Kung University, Tainan, Taiwan.

Metformin, as an AMP-activated protein kinase (AMPK) activator, can activate autophagy. A study showed that metformin decreased the risk of hepatocellular carcinoma (HCC) in diabetic patients. However, the detailed mechanism in the metformin-mediated anticancer effect remains an open question. Transcription factor CCAAT/enhancer-binding protein delta (CEBPD) has been suggested to serve as a tumor suppressor and is responsive to multiple anticancer drugs in HCC. In this study, we found that CEBPD and autophagy are involved in metformin-induced cell apoptosis in Huh7 cells. The underlying mechanisms in this process included a reduction in Src-mediated CEBPD protein degradation and an increase in CEBPD-regulated LC3B and ATG3 gene transcription under metformin treatment. We also found that AMPK is involved in metformin-induced CEBPD expression. Combined treatment with metformin and rapamycin can enhance autophagic cell death through the AMPK-dependent and AMPK-independent pathway, respectively. Taken together, we provide a new insight and therapeutic approach by targeting autophagy in the treatment of HCC.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008687 Metformin A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) Dimethylguanylguanidine,Dimethylbiguanidine,Glucophage,Metformin HCl,Metformin Hydrochloride,HCl, Metformin,Hydrochloride, Metformin
D008856 Microscopy, Fluorescence Microscopy of specimens stained with fluorescent dye (usually fluorescein isothiocyanate) or of naturally fluorescent materials, which emit light when exposed to ultraviolet or blue light. Immunofluorescence microscopy utilizes antibodies that are labeled with fluorescent dye. Fluorescence Microscopy,Immunofluorescence Microscopy,Microscopy, Immunofluorescence,Fluorescence Microscopies,Immunofluorescence Microscopies,Microscopies, Fluorescence,Microscopies, Immunofluorescence
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

Hsin-Hwa Tsai, and Hong-Yue Lai, and Yueh-Chiu Chen, and Chien-Feng Li, and Huei-Sheng Huang, and Hsiao-Sheng Liu, and Yau-Sheng Tsai, and Ju-Ming Wang
December 2015, Diabetes & metabolism journal,
Hsin-Hwa Tsai, and Hong-Yue Lai, and Yueh-Chiu Chen, and Chien-Feng Li, and Huei-Sheng Huang, and Hsiao-Sheng Liu, and Yau-Sheng Tsai, and Ju-Ming Wang
November 2020, International immunopharmacology,
Hsin-Hwa Tsai, and Hong-Yue Lai, and Yueh-Chiu Chen, and Chien-Feng Li, and Huei-Sheng Huang, and Hsiao-Sheng Liu, and Yau-Sheng Tsai, and Ju-Ming Wang
April 2023, Journal of natural products,
Hsin-Hwa Tsai, and Hong-Yue Lai, and Yueh-Chiu Chen, and Chien-Feng Li, and Huei-Sheng Huang, and Hsiao-Sheng Liu, and Yau-Sheng Tsai, and Ju-Ming Wang
January 2017, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology,
Hsin-Hwa Tsai, and Hong-Yue Lai, and Yueh-Chiu Chen, and Chien-Feng Li, and Huei-Sheng Huang, and Hsiao-Sheng Liu, and Yau-Sheng Tsai, and Ju-Ming Wang
March 2019, Cancer science,
Hsin-Hwa Tsai, and Hong-Yue Lai, and Yueh-Chiu Chen, and Chien-Feng Li, and Huei-Sheng Huang, and Hsiao-Sheng Liu, and Yau-Sheng Tsai, and Ju-Ming Wang
August 2023, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica,
Hsin-Hwa Tsai, and Hong-Yue Lai, and Yueh-Chiu Chen, and Chien-Feng Li, and Huei-Sheng Huang, and Hsiao-Sheng Liu, and Yau-Sheng Tsai, and Ju-Ming Wang
January 2017, Cell death & disease,
Hsin-Hwa Tsai, and Hong-Yue Lai, and Yueh-Chiu Chen, and Chien-Feng Li, and Huei-Sheng Huang, and Hsiao-Sheng Liu, and Yau-Sheng Tsai, and Ju-Ming Wang
April 2017, Journal of pineal research,
Hsin-Hwa Tsai, and Hong-Yue Lai, and Yueh-Chiu Chen, and Chien-Feng Li, and Huei-Sheng Huang, and Hsiao-Sheng Liu, and Yau-Sheng Tsai, and Ju-Ming Wang
March 2017, Cell death & disease,
Hsin-Hwa Tsai, and Hong-Yue Lai, and Yueh-Chiu Chen, and Chien-Feng Li, and Huei-Sheng Huang, and Hsiao-Sheng Liu, and Yau-Sheng Tsai, and Ju-Ming Wang
January 2022, Contrast media & molecular imaging,
Copied contents to your clipboard!